Aclidinium Bromide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Aclidinium bromide;   Drug: Aclidinium bromide/formoterol;   Drug: Other COPD medication Sponsors:   AstraZeneca;   RTI Health Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Aclidinium bromide;   Drug: Other COPD medication Sponsors:   AstraZeneca;   RTI Health Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2017 Category: Research Source Type: clinical trials